Obsessive-Compulsive Disorder
Conditions
Brief summary
The overarching goal of this protocol is to investigate mechanisms that influence symptom outcomes of exposure and response prevention (ERP) therapy for OCD. Mechanisms may include affective processes, learning factors, cognitive factors, or other constructs that could influence treatment outcomes. The study team will conduct this research within the context of an effective online treatment for OCD called OCD-NET. OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD.
Interventions
BEHAVIORALOCD-NET
OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD. OCD-NET is a self-paced intervention that participants complete entirely online with the support of an assigned individual therapist. Most participants complete this treatment in up to twelve weeks. On average, participants are expected to spend between one to five hours per week during the first half of treatment. In the second half of treatment when participants begin regular exposure and response prevention (ERP) exercises, participants are expected to spend about one hour per day.
Sponsors
University of Miami
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* English-speaking * Located within the United States * 18-90 years old * Able to provide consent * Current diagnosis of OCD as assessed by clinical interview
Exclusion criteria
* Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Participants currently located outside of the United States * Prisoners * Participants with hoarding as the primary OCD symptom * Severe mental illness (e.g. schizophrenia, substance abuse); organic brain syndrome; or serious, current suicidal/homicidal ideation (based on phone screening or initial assessment) * Concurrent enrollment in another psychotherapy treatment * Participants taking psychotropic medication may be excluded if: * They have started a brand new psychotropic medication within the last 12 weeks * They have changed the dose of their psychotropic medication within the last 4 weeks * They anticipate that they cannot maintain the current dose of their psychotropic medication for the duration of the study * Participants may be excluded if they have any cognitive or physical impairments that would interfere with their participation (e.g., significant head injury, cognitive disability, dementia).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in OCD Symptoms Measured by Yale-Brown Obsessive Compulsive Scale-Second Edition (YBOCS-II) | Baseline, up to 12 months (end of treatment) | YBOCS-II scores range from 0-50, and higher scores indicate more severe illness |
Countries
United States
Outcome results
None listed